State Ledger
Company profile

Arcadia Biosciences, Inc. CIK 1469443

Ticker
RKDA (Nasdaq)
Industry
Crude Petroleum & Natural Gas
Headquarters
Dallas, TX
Fiscal year end
2025 (FY)
Market Data
Close
$0.26
Change
-$0.02
Change %
-6.39%
Volume
2,900

RKDA · trading date Oct 9, 2026 · previous close $0.27 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$4.86M
Net income
-$2.34M
Total assets
$6.55M
Total liabilities
$2.41M
Stockholders' equity
$4.14M
Cash & equivalents
$259.0K
Operating income
-$2.50M
Operating cash flow
-$4.74M
Capital expenditures
$0

Fiscal year 2025, via 10-K filed 2026-03-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-51.5%
Net margin
-48.1%
Free cash flow
-$4.74M
Free cash flow margin
-97.6%
Liabilities / assets
36.8%
Equity / assets
63.2%
CapEx / revenue
0.0%
Operating cash flow / net income
2.03×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $4.86M -$2.34M $6.55M $2.41M $4.14M
2024 $5.05M -$7.04M $13.52M $7.29M $6.22M
2023 $4.45M -$13.98M $19.71M $7.00M $12.84M
2022 $7.42M -$15.38M $28.92M $8.02M $21.03M
2021 $6.78M -$14.66M $43.92M $12.72M $31.09M
Company Details
SIC code
1311
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-15
Financials filed via
Form 10-K
filed 2026-03-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Dallas, TX
5956 SHERRY LANE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:56 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies